This application requests renewal of a grant to provide advanced, state-of-the-art training in two active and closely related fields, angiogenesis and inflammation. Training of new scientists and physician-scientists in these areas is vital to the continued discovery of basic mechanisms that regulate these processes, which are central to many human diseases. Despite a growing need, few opportunities provide broad, in depth, interdisciplinary training for individuals to investigate the complex and interrelated processes that regulate normal and pathological angiogenesis and inflammatory responses. The training is based in the Department of Pathology at the Beth Israel Deaconess Medical Center (BIDMC) and focuses on both basic and translational research. The training program for each participant includes four components, (a) research training in one or more faculty member's laboratory, (b) participation in seminar series as speakers and attendees, (c) participation in a program on the responsible conduct of research (RCR), and (d) participation in relevant graduate courses offered by Harvard Medical School and Harvard University. The members of the training faculty have been selected on the basis of their commitment to mentoring and collaborative research. They will mentor the trainees in the insightful design of experiments with appropriate controls, grant writing, career development, and the RCR. Many of the faculty members have shared projects and trainees are encouraged to participate in these collaborative projects, which offer an opportunity to learn new methodologies. The program faculty members have extensive experience in biochemistry, cell biology, molecular biology, pathology and animal models of disease. The trainees will gain experience with new technologies in the fields of genomics, proteomics and molecular diagnostics, stem cell biology, computational modeling and bioinformatics. As part of the Harvard Medical School and the Longwood Medical Area, the BIDMC is ideally positioned to provide trainees with experience in state-of-the-art technologies and opportunities to interact with outstanding scientists. We propose to train six postdoctoral fellows each year, selected from applicants with Ph.D., M.D., or M.D./Ph.D. degrees. The BIDMC and Harvard Medical School have a strong commitment to the recruitment, retention, and encouragement of under-represented minorities, the disabled and individuals from disadvantaged backgrounds.
Angiogenesis and inflammation are central processes in many physiological and pathological conditions, including cancer. This application requests renewal of a grant to provide advanced, state-of-the-art training in two active and closely related fields, angiogenesis and inflammation. Despite a growing need, few opportunities provide broad, in depth, interdisciplinary training for individuals to investigate the complex and interrelated processes that regulate angiogenesis and inflammatory responses.
|Dai, Xiangpeng; Liu, Pengda; Lau, Alan W et al. (2014) Acetylation-dependent regulation of essential iPS-inducing factors: a regulatory crossroad for pluripotency and tumorigenesis. Cancer Med 3:1211-24|
|Wang, Zhiwei; Liu, Pengda; Inuzuka, Hiroyuki et al. (2014) Roles of F-box proteins in cancer. Nat Rev Cancer 14:233-47|
|Liu, Pengda; Guo, Jianping; Gan, Wenjian et al. (2014) Dual phosphorylation of Sin1 at T86 and T398 negatively regulates mTORC2 complex integrity and activity. Protein Cell 5:171-7|
|Liu, Pengda; Begley, Michael; Michowski, Wojciech et al. (2014) Cell-cycle-regulated activation of Akt kinase by phosphorylation at its carboxyl terminus. Nature 508:541-5|
|Menon, Suchithra; Dibble, Christian C; Talbott, George et al. (2014) Spatial control of the TSC complex integrates insulin and nutrient regulation of mTORC1 at the lysosome. Cell 156:771-85|
|Thornley, Thomas B; Fang, Zemin; Balasubramanian, Savithri et al. (2014) Fragile TIM-4-expressing tissue resident macrophages are migratory and immunoregulatory. J Clin Invest 124:3443-54|
|Liu, Jia; Wan, Lixin; Liu, Pengda et al. (2014) SCF(?-TRCP)-mediated degradation of NEDD4 inhibits tumorigenesis through modulating the PTEN/Akt signaling pathway. Oncotarget 5:1026-37|
|Liu, Pengda; Gan, Wenjian; Inuzuka, Hiroyuki et al. (2013) Sin1 phosphorylation impairs mTORC2 complex integrity and inhibits downstream Akt signalling to suppress tumorigenesis. Nat Cell Biol 15:1340-50|
|Yiu, Gary K; Kaunisto, Aura; Chin, Y Rebecca et al. (2011) NFAT promotes carcinoma invasive migration through glypican-6. Biochem J 440:157-66|
|Singh, Amrik; Plati, Jessica; Khosravi-Far, Roya (2011) Harnessing the tumor suppressor function of FOXO as an alternative therapeutic approach in cancer. Curr Drug Targets 12:1311-21|
Showing the most recent 10 out of 22 publications